1. Home
  2. CATX vs EOLS Comparison

CATX vs EOLS Comparison

Compare CATX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$2.97

Market Cap

414.0M

Sector

Health Care

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.75

Market Cap

454.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATX
EOLS
Founded
1983
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.0M
454.4M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
CATX
EOLS
Price
$2.97
$5.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$12.11
$15.50
AVG Volume (30 Days)
2.6M
776.9K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$1.96
$3.86
52 Week High
$6.16
$10.20

Technical Indicators

Market Signals
Indicator
CATX
EOLS
Relative Strength Index (RSI) 41.91 36.03
Support Level $2.86 $4.02
Resistance Level $4.27 $7.16
Average True Range (ATR) 0.23 0.35
MACD -0.02 -0.15
Stochastic Oscillator 16.15 18.12

Price Performance

Historical Comparison
CATX
EOLS

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: